Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.

From giant worms, grizzly bears, and alligators, to vengeance-seeking killer whales, it seems that even before Steven ...

Compounding pharmacies are supposed to stop producing the compounded versions of the popular weight loss medications now that ...

When his wife’s mental-health struggles and his own malaise threatened their life together, the author discovered the joys of ...

With President Donald Trump's tariffs wreaking havoc on California’s economy and health costs rising, state leaders will have ...

ARSENAL are looking ahead to a HUGE summer transfer window after another trophyless season. The Gunners have been linked with ...

ARSENAL are looking ahead to a HUGE summer transfer window after another trophyless season. The Gunners have reportedly been ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to halt the sale and production of off-brand products that many patients in ...

In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the company. The Danish pharmaceutical giant announced Friday that ...

Ozempic and Wegovy maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.

Ozempic shaming is obnoxious and hurtful. It’s also a good example of the broader issues in our society around bias, misinformation, and discrimination. If you survived middle school without ...